NFKB1 and periodontitis: This study evaluated FA’s effects on inflammation and osteogenic function in LPS‐induced hPDLSCs, revealing its potential to alleviate periodontitis via NF‐κB pathway inhibition and identifying a possible therapeutic target for periodontal disease.